Cancer Research Targets Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haudenschild, D. R.
Right arrow Articles by Reddi, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haudenschild, D. R.
Right arrow Articles by Reddi, A. H.
[Cancer Research 64, 8276-8284, November 15, 2004]
© 2004 American Association for Cancer Research

Regular Articles

Bone Morphogenetic Protein (BMP)-6 Signaling and BMP Antagonist Noggin in Prostate Cancer

Dominik R. Haudenschild, Sabrina M. Palmer, Timothy A. Moseley, Zongbing You and A. Hari Reddi

Center for Tissue Regeneration and Repair, Department of Orthopedic Surgery, School of Medicine, University of California, Davis, Sacramento, California

It has been proposed that the osteoblastic nature of prostate cancer skeletal metastases is due in part to elevated activity of bone morphogenetic proteins (BMPs). BMPs are osteoinductive morphogens, and elevated expression of BMP-6 correlates with skeletal metastases of prostate cancer. In this study, we investigated the expression levels of BMPs and their modulators in prostate, using microarray analysis of cell cultures and gene expression. Addition of exogenous BMP-6 to DU-145 prostate cancer cell cultures inhibited their growth by up-regulation of several cyclin-dependent kinase inhibitors such as p21/CIP, p18, and p19. Expression of noggin, a BMP antagonist, was significantly up-regulated by BMP-6 by microarray analysis and was confirmed by quantitative reverse transcription-polymerase chain reaction and at the protein level. Noggin protein was present in prostate biopsies and localized to the epithelial components of prostate by immunohistochemistry. Recombinant noggin inhibited the function of BMP-6, suggesting a negative feedback regulation of BMP activity and indicating a strategy for the development of a novel therapeutic target in the treatment of painful osteosclerotic bone metastases of prostate cancer.




This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
Z. Huang, D. Wang, K. Ihida-Stansbury, P. L. Jones, and J. F. Martin
Defective pulmonary vascular remodeling in Smad8 mutant mice
Hum. Mol. Genet., August 1, 2009; 18(15): 2791 - 2801.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
L. Ye, H. Kynaston, and W. G. Jiang
Bone Morphogenetic Protein-9 Induces Apoptosis in Prostate Cancer Cells, the Role of Prostate Apoptosis Response-4
Mol. Cancer Res., October 1, 2008; 6(10): 1594 - 1606.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
K. R. Blish, W. Wang, M. C. Willingham, W. Du, C. E. Birse, S. R. Krishnan, J. C. Brown, G. A. Hawkins, A. J. Garvin, R. B. D'Agostino Jr., et al.
A Human Bone Morphogenetic Protein Antagonist Is Down-Regulated in Renal Cancer
Mol. Biol. Cell, February 1, 2008; 19(2): 457 - 464.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Daibata, Y. Nemoto, K. Bandobashi, N. Kotani, M. Kuroda, M. Tsuchiya, H. Okuda, T. Takakuwa, S. Imai, T. Shuin, et al.
Promoter Hypermethylation of the Bone Morphogenetic Protein-6 Gene in Malignant Lymphoma
Clin. Cancer Res., June 15, 2007; 13(12): 3528 - 3535.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B. L. Theriault, T. G. Shepherd, M. L. Mujoomdar, and M. W. Nachtigal
BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells
Carcinogenesis, June 1, 2007; 28(6): 1153 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Schwaninger, C. A. Rentsch, A. Wetterwald, G. van der Horst, R. L. van Bezooijen, G. van der Pluijm, C. W.G.M. Lowik, K. Ackermann, W. Pyerin, F. C. Hamdy, et al.
Lack of Noggin Expression by Cancer Cells Is a Determinant of the Osteoblast Response in Bone Metastases
Am. J. Pathol., January 1, 2007; 170(1): 160 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. L. Vessella and E. Corey
Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.
Clin. Cancer Res., October 15, 2006; 12(20): 6285s - 6290s.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
F. Moll, C. Millet, D. Noel, B. Orsetti, A. Bardin, D. Katsaros, C. Jorgensen, M. Garcia, C. Theillet, P. Pujol, et al.
Chordin is underexpressed in ovarian tumors and reduces tumor cell motility
FASEB J, February 1, 2006; 20(2): 240 - 250.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Dai, J. Keller, J. Zhang, Y. Lu, Z. Yao, and E. T. Keller
Bone Morphogenetic Protein-6 Promotes Osteoblastic Prostate Cancer Bone Metastases through a Dual Mechanism
Cancer Res., September 15, 2005; 65(18): 8274 - 8285.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.